Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Study Type: INTERVENTIONAL
Official Title: Antimicrobial Revision in Patients With Persistent Febrile Neutropenia: A Prospective, Randomized Trial
Brief Summary: Febrile neutropenia is often seen in patients with hematologic malignancies who receive cytotoxic chemotherapy.
These patients are usually placed on posaconazole prophylaxis upon starting chemotherapy.
If an episode of febrile neutropenia occurs, generally an anti-pseudomonal beta lactam, like cefepime or piperacillin-tazobactam, is initiated.
In patients who continue to fever on these agents, the optimal method of antimicrobial revision has yet to be determined.